Literature DB >> 14675346

Visual inspection with acetic acid and cytology in the early detection of cervical neoplasia in Kolkata, India.

P S Basu1, R Sankaranarayanan, R Mandal, C Roy, P Das, D Choudhury, D Bhattacharya, R Chatterjee, K Dutta, S Barik, V Tsu, R N Chakrabarti, M Siddiqi.   

Abstract

Visual inspection of the cervix after application of 3-5% acetic acid (VIA) is a potential alternative to cytology for screening in low-resource countries. The present study evaluated the performance of VIA, magnified visual inspection after application of acetic acid (VIAM), and cytology in the detection of high-grade cervical cancer precursor lesions in Kolkata (Calcutta) and suburbs in eastern India. Trained health workers with college education concurrently screened 5881 women aged 30-64 years with VIA, VIAM, and conventional cervical cytology. Detection of well-defined, opaque acetowhite lesions close to the squamocolumnar junction; well-defined, circumorificial acetowhite lesions; or dense acetowhitening of ulceroproliferative growth on the cervix constituted a positive VIA or VIAM. Cytology was considered positive if reported as mild dysplasia or worse lesions. All screened women (N = 5881) were evaluated by colposcopy, and biopsies were directed in those with colposcopic abnormalities (N = 1052, 17.9%). The final diagnosis was based on histology (if biopsies had been taken) or colposcopic findings, which allowed direct estimation of sensitivity, specificity, and predictive values. Moderate or severe dysplasia or carcinoma in situ (CIN 2-3 disease) was considered as true positive disease for the calculation of sensitivity, specificity, and predictive values of screening tests. 18.7%, 17.7% and 8.2% of the women tested positive for VIA, VIAM, and cytology. One hundred twenty two women had a final diagnosis of CIN 2-3 lesions. The sensitivities of VIA and VIAM to detect CIN 2-3 lesions were 55.7% and 60.7%, respectively; the specificities were 82.1% and 83.2%, respectively. The sensitivity and specificity of cytology were 29.5% and 92.3%, respectively. All the tests were associated with negative predictive values above 98%. VIA and VIAM had significantly higher sensitivity than cytology in our study; the specificity of cytology was higher than that of VIA and VIAM.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14675346     DOI: 10.1046/j.1525-1438.2003.13394.x

Source DB:  PubMed          Journal:  Int J Gynecol Cancer        ISSN: 1048-891X            Impact factor:   3.437


  14 in total

1.  A comparison of triage methods for Kenyan women who screen positive for cervical intraepithelial neoplasia by visual inspection of the cervix with acetic acid.

Authors:  K C L Lewis; V D Tsu; A Dawa; N A Kidula; I N Chami; J W Sellors
Journal:  Afr Health Sci       Date:  2011-09       Impact factor: 0.927

2.  Cervical cancer awareness and screening in Botswana.

Authors:  Alicea M Mingo; Catherine A Panozzo; Yumi Taylor DiAngi; Jennifer S Smith; Andrew P Steenhoff; Doreen Ramogola-Masire; Noel T Brewer
Journal:  Int J Gynecol Cancer       Date:  2012-05       Impact factor: 3.437

Review 3.  Implementing community-based cervical cancer screening programs using visual inspection with acetic acid in India: A systematic review.

Authors:  Prajakta Adsul; Nitin Manjunath; Vijaya Srinivas; Anjali Arun; Purnima Madhivanan
Journal:  Cancer Epidemiol       Date:  2017-07-10       Impact factor: 2.984

4.  Correlation of Cytology and Colposcopic Findings Using Reid's Index in VIA-Positive Women.

Authors:  Nisarg Dharaiya; Nandita Maitra
Journal:  J Obstet Gynaecol India       Date:  2014-04-12

Review 5.  Advancing cervical cancer prevention in India: implementation science priorities.

Authors:  Suneeta Krishnan; Emily Madsen; Deborah Porterfield; Beena Varghese
Journal:  Oncologist       Date:  2013-11-11

6.  Prevalence of human papilloma virus infection in women in rural Ethiopia.

Authors:  R Ruland; C Prugger; R Schiffer; M Regidor; R J Lellé
Journal:  Eur J Epidemiol       Date:  2006-10-27       Impact factor: 8.082

7.  Effectiveness of VIA, Pap, and HPV DNA testing in a cervical cancer screening program in a peri-urban community in Andhra Pradesh, India.

Authors:  Patti E Gravitt; Proma Paul; Hormuzd A Katki; Haripriya Vendantham; Gayatri Ramakrishna; Mrudula Sudula; Basany Kalpana; Brigitte M Ronnett; K Vijayaraghavan; Keerti V Shah
Journal:  PLoS One       Date:  2010-10-28       Impact factor: 3.240

8.  Cervical cancer screening in primary health care setting in Sudan: a comparative study of visual inspection with acetic acid and Pap smear.

Authors:  Ahmed Ibrahim; Arja R Aro; Vibeke Rasch; Eero Pukkala
Journal:  Int J Womens Health       Date:  2012-02-28

Review 9.  Cancer Screening: Should Cancer Screening be Essential Component of Primary Health Care in Developing Countries?

Authors:  Saurabh Bobdey; Ganesh Balasubramanium; Abhinendra Kumar; Aanchal Jain
Journal:  Int J Prev Med       Date:  2015-07-06

10.  Cervical Cancer Screening Program by Visual Inspection: Acceptability and Feasibility in Health Insurance Companies.

Authors:  Apollinaire G Horo; Judith Didi-Kouko Coulibaly; Abdoul Koffi; Boris Tchounga; Konan Seni; Kacou Edèle Aka; Mamourou Kone
Journal:  Obstet Gynecol Int       Date:  2015-06-18
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.